Filing Details

Accession Number:
0000899243-17-024381
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-17 17:11:52
Reporting Period:
2017-10-13
Accepted Time:
2017-10-17 17:11:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1374690 Zafgen Inc. ZFGN Pharmaceutical Preparations (2834) 203857670
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1441724 K Frances Heller C/O Zafgen, Inc.
175 Portland Street, 4Th Floor
Boston MA 02114
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-13 10,000 $3.90 47,961 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.8645 to $3.92, inclusive. The reporting person undertakes to provide to Zafgen, Inc., any security holder of Zafgen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
  2. Total number of shares includes 7,961 shares of Common Stock acquired by the Reporting Person on December 31, 2012 that were not previously reported.